Search

Your search keyword '"ILF2"' showing total 40 results

Search Constraints

Start Over You searched for: Descriptor "ILF2" Remove constraint Descriptor: "ILF2"
40 results on '"ILF2"'

Search Results

1. ILF2 protein is a promising serum biomarker for early detection of gastric cancer

2. ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target.

3. ILF2 protein is a promising serum biomarker for early detection of gastric cancer.

4. ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target

5. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer

6. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.

7. The interleukin enhancer binding factor-2 (ILF2) gene in Penaeus japonicus shrimp: cloning, tissue distribution, and antiviral effects.

8. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis

9. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.

10. LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2.

11. NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer.

12. ILF2 Contributes to Hyperproliferation of Keratinocytes and Skin Inflammation in a KLHDC7B-DT-Dependent Manner in Psoriasis.

13. ILF2 Contributes to Hyperproliferation of Keratinocytes and Skin Inflammation in a KLHDC7B-DT-Dependent Manner in Psoriasis

14. Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy.

15. Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma

16. Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.

17. Circular RNA 406961 interacts with ILF2 to regulate PM2.5-induced inflammatory responses in human bronchial epithelial cells via activation of STAT3/JNK pathways

18. Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing

19. Deletion of interleukin enhancer binding factor 2 (ILF2) resulted in defective biliary development and bile flow blockage.

20. Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets

21. Eriocheir sinensis microRNA-7 targets crab Myd88 to enhance white spot syndrome virus replication.

22. Interleukin-enhanced binding factor 2 interacts with NLRP3 to inhibit the NLRP3 inflammasome activation.

23. Enterovirus 71 Represses Interleukin Enhancer-Binding Factor 2 Production and Nucleus Translocation to Antagonize ILF2 Antiviral Effects

26. Characterization of nuclear factor of activated T-cells-c3 (NFATc3) and gene expression of upstream-downstream signaling molecules in response to immunostimulants in Pacific red snapper cells.

27. Protein partners of the eEF1Bβ subunit of the translation elongation complex eEF1B in the nuclear fraction of human lung carcinoma cells.

28. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.

29. Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets

30. Circular RNA 406961 interacts with ILF2 to regulate PM2.5-induced inflammatory responses in human bronchial epithelial cells via activation of STAT3/JNK pathways

31. An interleukin-2 enhancer binding factor 2 homolog involved in immune response from Chinese mitten crab Eriocheir sinensis

32. Ilf2 is regulated during meiosis and associated to transcriptionally active chromatin

33. Unbiased identification of trans regulators of ADAR and A-to-I RNA editing

34. Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).

35. Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.

36. Enterovirus 71 Represses Interleukin Enhancer-Binding Factor 2 Production and Nucleus Translocation to Antagonize ILF2 Antiviral Effects.

37. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma.

38. Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.

39. The long noncoding RNA LINC00473, a target of microRNA 34a, promotes tumorigenesis by inhibiting ILF2 degradation in cervical cancer.

40. Analysis of protein expression in zebrafish during gonad differentiation by targeted proteomics.

Catalog

Books, media, physical & digital resources